CD4 and neoplasm: Unlike CD8+ T cells and previously mentioned CD4+ subgroups, CD4+ regulatory T (Treg) cells characterized by the high expression of CD25 and FOXP3 suppress CD8+ T cells by counteracting tumor immune response.186